Agilent 1290 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases

Similar documents
Fast and Flexible Optimization of Modifier Concentrations Using an Agilent 1290 Infinity LC System with Blend Assist

Performance characteristics of the Agilent 1290 Infinity Quaternary Pump

Application Note. Author. Abstract. Pharmaceutical QA/QC. Siji Joseph Agilent Technologies, Inc. Bangalore, India

High-Resolution Sampling 2D-LC for Pharmaceutical Impurity Analysis

Agilent 1200 Infinity Series HDR DAD Impurity Analyzer System for the Quantification of Trace Level of Genotoxic Impurity

Analysis of Stachydrine in Leonurus japonicus Using an Agilent ZORBAX RRHD HILIC Plus Column with LC/ELSD and LC/MS/MS

Automated Switching Between 1D-LC and Comprehensive 2D-LC Analysis

LC walk-up system using the Agilent 1200 Series LC Method Development Solution and Agilent Easy Access software. Application Note

Using the Agilent 1290 Infinity II Multicolumn Thermostat with Extreme Temperatures and Flow Rates

Performance evaluation of the Agilent 1290 Infinity 2D-LC Solution for comprehensive two-dimensional liquid chromatography

The Agilent 1260 Infinity Analytical SFC System with Time-of-Flight Mass Spectrometric Detection

Analysis of DNPH-derivatized Aldehydes and Ketones using the Agilent 1220 Infinity LC System with Diode Array Detector

The Agilent InfinityLab 2D-LC Solution with Active Solvent Modulation

Developing a fast, generic method for rapid resolution LC with quadrupole MS detection. Application Note

Application Note. Author. Abstract. Xinlei Yang Agilent Technologies Co. Ltd Shanghai, China

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Application Note. Pharmaceutical QA/QC. Author. Abstract. Siji Joseph Agilent Technologies, Inc. Bangalore, India

Analysis of Positional Isomers of Lapatinib with Agilent Poroshell 120 PFP Columns

Application Note. Author. Abstract. Food Testing & Agriculture. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Application Note. Authors. Abstract. Energy & Chemicals, Biofuels & Alternative Energy

Ultrafast and sensitive analysis of sweeteners, preservatives and flavorants in nonalcoholic beverages using the Agilent 1290 Infinity LC system

Analysis of Beer by Comprehensive 2D-LC with the Agilent 1290 Infinity 2D-LC system

Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF. Application Note. Donghui Yi and Christine Miller Agilent Technologies

Comprehensive 2D-LC Analysis of Chinese Herbal Medicine

Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS

Rapid Screening and Analysis of Components in Nonalcoholic Drinks Application

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

Quantification of growth promoters olaquindox and carbadox in animal feedstuff with the Agilent 1260 Infinity Binary LC system with UV detection

Accurate quantification of oleanolic acid and ursolic acid in traditional chinese medicine

Application Note. Author. Abstract. Pharmaceutical QA/QC. Vinayak A.K Agilent Technologies Bangalore, India

Separation of Enantiomers of Amphetamine-Related Drugs and Their Structural Isomers

Plasma Metanephrines and 3-Methoxytyramine by LC/MS/MS Using Agilent SimpliQ WCX SPE, 1290 Infi nity LC, and 6460 Triple Quadrupole LC/MS

Separation of Explosives in EPA 8330: Column Choices Optimize Speed, Resolution, and Solvent Use. Application. Authors. Abstract.

Automating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents

Application. Authors. Abstract. Introduction. Hydrocarbon Processing

Exceptional Selectivity of Agilent ZORBAX Eclipse Plus Phenyl-Hexyl Columns to Separate Estrogens

Application Note. Abstract. Authors. Pharmaceutical. William J. Long Agilent Technologies, Inc Centerville Road Wilmington, DE USA

Value of Eclipse Plus C18 and ph Selectivity to Analyze Amine-Containing Drugs

Analysis of Metals, Halides, and Inorganic Ions Using Hydrophilic Interaction Chromatography

Application Note. Edgar Naegele. Abstract

Pharmaceutical Impurity Identification and Profiling Using Agilent Q-TOF LC/MS Combined with Advanced MassHunter Data Processing Software

Application Note. Agilent Application Solution Analysis of acaricides in honey. Authors. Abstract. Food

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

Agilent LC & LC-MS Cannabis Testing

Fast Screening Methods for Steroids by HPLC with Agilent Poroshell 120 Columns

Application Note Pharmaceutical QA/QC. Agilent Application Solution. Authors. Abstract. Syed Salman Lateef Agilent Technologies, Inc.

ACD/AutoChrom Assisted Method Development for Challenging Separations. Vera Leshchinskaya February 7, 2018

Achieve confident synthesis control with the Thermo Scientific ISQ EC single quadrupole mass spectrometer

Routine MS Detection for USP Chromatographic Methods

The Secrets of Rapid HPLC Method Development. Choosing Columns for Rapid Method Development and Short Analysis Times

The new Agilent 1290 Infinity Quaternary LC

Agilent All Ions MS/MS

Agilent s New Weak Anion Exchange (WAX) Solid Phase Extraction Cartridges: SampliQ WAX

770-9P. Sensitivity and Selectivity - A Case Study of LC/MS Enantioselective Resolution of Bupivacaine Using Vancomycin as a Chiral Stationary Phase

Modernizing the USP Monograph for Acetaminophen

Analysis of E.coli Tryptic Digest and Intact Protein Using the Agilent 1290 Infinity 2D-LC Solution with Diode Array Detection and Q-TOF LC/MS

Peptide and protein analysis by capillary HPLC Optimization of chromatographic and instrument parameters. Application. Angelika Gratzfeld-Huesgen

Detection of Trace Level Pharmaceuticals in Drinking Water by Online SPE Enrichment with the Agilent 1200 Infinity Series Online-SPE Solution

Application Note. Authors. Abstract. Food Testing & Agriculture. Stephen E. Reichenbach University of Nebraska Lincoln, NE, USA

The Analysis of Organophosphate Pesticides by LC/MS Application

mau 200 ph min

Accurate Mass Analysis of Hydraulic Fracturing Waters: Identification of Polyethylene Glycol Surfactants by LC/Q-TOF-MS

Application Note. David A. Weil Zoltan Timar Michael Zumwalt Edgar Naegele. Abstract

Analysis of Phthalates in Body Wash using Solid-Supported Liquid-Liquid Extraction

Quantitative Analysis of Water-Soluble B-Vitamins in Cereal Using Rapid Resolution LC/MS/MS. Application. Authors. Abstract.

MassHunter METLIN Metabolite PCD/PCDL Quick Start Guide

Application Note. Edgar Naegele. Abstract

Agilent 6460 Triple Quadrupole LC/MS System with an Agilent 1290 Infinity LC For Multi-Plant Growth Regulator Analysis in Grapes

Welcome to our E-Seminar: Choosing HPLC Columns for Faster Analysis Smaller and Faster

Accelerating the Metabolite Identification Process Using High Resolution Q-TOF Data and Mass-MetaSite Software

Analysis of Positional Isomers with Agilent Poroshell 120 PFP Columns

Determination of Hormones in Drinking Water by LC/MS/MS Using an Agilent InfinityLab Poroshell HPH Column (EPA 539)

penta-hilic UHPLC COLUMNS

All Ions MS/MS: Targeted Screening and Quantitation Using Agilent TOF and Q-TOF LC/MS Systems

Automated method development using Agilent 1100 Series HPLC systems, Agilent ChemStation and ChromSword software. Application

Polymer analysis by GPC-SEC. Technical Note. Introduction

Computer-assisted analysis of complex natural product extracts

Analysis of Cannabinoids and Amphetamines in Serum by RRLC/Triple Quadrupole Mass Spectrometry Using a Multimode Ion Source. Application.

Metabolomics Batch Data Analysis Workflow to Characterize Differential Metabolites in Bacteria

Shodex TM ODP2 HP series columns

LC/MS/MS of Fungicides and Metabolites in Apple Juice with Agilent Bond Elut Plexa and Poroshell 120

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

Acclaim Mixed-Mode WCX-1

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

Accurate Mass Analysis of Hydraulic Fracturing Waters

Sensitive Femtogram Determination of Aflatoxins B 1 , B 2 , G 1. and G 2. in Food Matrices using Triple Quadrupole LC/MS. Authors.

HPLC Preparative Scaleup of Calcium Channel Blocker Pharmaceuticals Application

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Application Note. Agilent Application Solution Analysis of PAHs in soil according to EPA 8310 method with UV and fluorescence detection.

Determination of Verapamil Hydrochloride Purity Using the Acclaim PA Column

Analysis of Low-Calorie Sweeteners by Liquid Chromatography-Tandem Mass Spectrometry

LC Technical Information

Choosing Columns and Conditions for the Best Peak Shape

Method Development in Comprehensive 2D-LC Finding the Most Orthogonal Separation Systems for RPLC RPLC Using Column and Solvent Screening

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Macrolides in Honey Using Agilent Bond Elut Plexa SPE, Poroshell 120, and LC/MS/MS

An Effective Workflow for Impurity Analysis Incorporating High Quality HRAM LCMS & MSMS with Intelligent Automated Data Mining

The Agilent 1290 Infinity II Multi Method Solution

Fast Screening Methods for Analgesics and Non-Steroidal Anti-Inflammatory Drugs by HPLC

for Acclaim Mixed-Mode WCX-1

Transcription:

Agilent 129 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases Technical Overview Author A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany Abstract The Agilent 129 Infi nity Quaternary Pump supports fast and convenient method development due to its ability to run ternary and quaternary gradients. This helps to transfer a method containing non-ms compatible mobile phases using nonvolatile buffers to a method using MS compatible mobile phases. The stepwise change from one modifi er to the other permits keeping track of the elution change. This Technical Overview describes how a method, based on phosphate buffer, was changed to a MS compatible method through a stepwise replacement of buffers containing ammonium acetate or formic acid. The developed MS method was transferred to the Agilent 129 Infi nity Binary LC/MS system. 2 1 % phosphate buffer % FA % phosphate buffer % FA 3 4 6 7 8 9 11 12

Introduction The 129 Infinity Quaternary Pump supports fast and convenient method development due to its ability to run ternary and quaternary gradients. Ternary and quaternary gradients are often used to keep buffer and modifier concentration of a mobile phase mixture constant while using two other channels to run a water/organic gradient. This workflow is extremely helpful for method optimization without preparing several mobile phase sets. The optimum concentration can easily be found, by changing the percentage of the modifier channel from run to run. It is also possible to test different modifiers in one sequence by applying two ternary gradients in series using first, the modifier placed in channel C, and then the modifier placed in channel D. This Technical Overview demonstrates a workflow to transfer a method with mobile phases not compatible with MS into a method with MS-compatible mobile phases. If, for example, a method was developed using NaH 2 PO 4 as buffer, the direct transfer to a MS is not possible. A method compatible with MS needs buffers or modifiers which evaporate in the ion source, such as ammonium acetate or formic acid. Direct injection of the compound mixture onto a LC/MS system using the new modifier implies that the compounds are all known and identification is done through MS spectra. If unknown compounds are present in the compound mixture, the correct correlation between peaks of the LC chromatogram and the MS chromatogram might not be possible, because the elution of the peaks could have changed using the new modifier. Experimental Instrumentation Agilent 129 Infinity Quaternary LC System Agilent 129 Infinity Quaternary Pump Agilent 129 Infinity Autosampler Agilent 129 Infinity Thermostat Agilent 129 Infinity Thermostatted Column Compartment Agilent 129 Infinity Diode Array Detector Agilent 129 Infinity Binary LC/MS System Agilent 129 Infinity Binary Pump Agilent 129 Infinity Autosampler Agilent 129 Infinity Thermostat Agilent 129 Infinity Thermostatted Column Compartment Agilent 129 Infinity Diode Array Detector Agilent 614 Quadrupole Mass Spectrometer Acquisition and Evaluation Software OpenLAB CDS ChemStation version C.1.4 A solution is to stepwise increase the concentration of the MS compatible modifier while, at the same time, the phosphate buffer concentration is decreasing on the 129 Infinity Quaternary UV LC system. By applying a stepwise change, peak tracking is relieved using peak heights or peak areas and UV spectra for identification. Having identified the peak elution difference for the MS compatible modifier, the new method can be passed on to a LC/MS system. Model number G44A G4226A G13B G1316C G4212A Model number G42A G4226A G13B G1316C G4212A G614A 2

Chromatographic Conditions Agilent 129 Infinity Quaternary LC Parameter Setting Column Agilent ZORBAX RRHT Eclipse Plus C18, 4.6 mm, 1.8 µm (p/n 99964-92) Mobile phases A = water 4% B = methanol 4%, C = mm KH 2 PO 4, ph 7 (adjusted with NaOH) D = mm Ammonium acetate, ph 6.9, or D = 1% formic acid solution, ph 2.1 Gradient 1 4% B to 6% B in utes, at utes 8% B, C=%, D=% Gradient 2 4% B to 6% B in utes, at utes 8% B, C=8%, D=2% Gradient 3 4% B to 6% B in utes, at utes 8% B, C=6%, D=4% Gradient 4 4% B to 6% B in utes, at utes 8% B, C=4%, D=6% Gradient 4% B to 6% B in utes, at utes 8% B, C=2%, D=8% Gradient 6 4% B to 6% B in utes, at utes 8% B, C=%, D=% Flow rate 1.2 ml/ Injection volume µl Column temperature 4 C Detection 24/, Ref 4/8, Hz Transfer from phosphate buffer to ammonium acetate or formic acid solution. Increasing D in 2% steps and decreasing C in 2% steps simultaneously. Chromatographic Conditions Agilent 129 Infinity Binary LC/MS Parameter Setting Column Agilent ZORBAX RRHT Eclipse Plus C18, 2.1 mm, 1.8 µm (p/n 99764-92) Mobile phases A = water +.1% formic acid, B = methanol Gradient % B to 6% B in utes, at utes 8% B Flow rate.4 ml/ Injection volume. µl Column temperature C Detection MSD full scan with extracted ion mode Ionization mode API-ES Polarity positive Mass range to 6 Fragmentor 7 Peak width.2 utes 3

Analyzed Compounds Tricyclic antidepressants, used as example compounds, were purchased from Sigma Aldrich Chemie GmbH, Germany. The compounds were dissolved in distilled water. H Results and Discussion Due to the structure of these molecules, the separation strongly depends on the ph. The pka values of these compounds are > 9 except for trimipra (pka = 8). Choose a buffer eluent with 2 ph units above or below the pka values of the analytes. The original LC method was based on a phosphate buffer at ph = 7. Ammonium acetate was chosen as MS compatible solvent because the 6.9 ph was close to the ph of the phosphate buffer. Formic acid was used as MS compatible modifier in a second experiment, because it is frequently used for MS analysis. Amitriptyline Imiprae Nortriptyline H 3 C H 3 C H H HCl H Protriptyline Trimiprae, R and S racemate Table 1. Molecular weights and pka values for analyzed compounds. Compound pka value Molecular weight MSD extracted ion Nortriptyline HCl 9.7 299.84 264 Protriptyline HCl 299.84 264 Amitriptyline HCl 9.4 313.86 278 Trimiprae maleate salt 8 4.1 267 Imiprae HCl 9.4 316.87 281 4

Using the 129 Infinity Quaternary Pump, four eluents are deployable. Water was placed in channel A, and methanol was placed in channel B. The eluents containing the modifiers were placed in channels C and D. Channel D contained mm ammonium acetate solution at ph 6.9, or 1% formic acid solution at ph 2.1. The resulting concentration of ammonium acetate in the final experiment was mm, respectively.1% formic acid. To demonstrate the transfer from a non-ms compatible method to a MS compatible method, the following experiments were performed: The 129 Infinity Quaternary Pump was used to analyze tricyclic antidepressant with mm phosphate buffer (channel C) at ph 7. Stepwise addition of ammonium acetate solution (channel D) at ph 6.9. Several methods with decreasing C and increasing D were applied. Six methods had to be set up to go from % C to % D in 2% steps. Stepwise addition of 1% formic acid solution (channel D) at ph 2.1. Several methods with decreasing C and increasing D were applied. Six methods had to be set up to go from % C to % D in 2% steps. Transfer of developed MS method with formic acid to a 129 Infinity Binary LC/MS system Methods were obtained which were compatible with MS. For peak tracking, peak heights and UV-spectra were used. 1 12 7 2 Amitriptyline 3 2 1 Nortriptyline 2 24 26 28 3 34 36 38 2 24 26 28 3 34 36 38 Protriptyline Trimiprae Imiprae 4 6 4 2 24 26 28 3 34 36 38 2 24 26 28 3 34 36 38 2 24 26 28 3 34 36 38 Figure 1. UV-spectra of analyzed compounds, used for identification in addition with peak height.

Figures 2 and 3 show an overlay of the six chromatograms with stepwise change of modifiers. Using the ammonium acetate modifier, the retention times shifted to lower values while the elution series remained unchanged. The resolution between the first peaks decreased compared to the chromatogram obtained using the phosphate buffer. Nevertheless, sufficient separation was obtained with ammonium acetate at ph 6.9. The same procedure was repeated with formic acid as the modifier. In this example, the elution series had changed, (Figure 3). All peaks shifted to lower retention times and resolution was significantly reduced. Amitriptylene was now the first peak and nortriptylene the last peak. Protriptylene and trimiprae coeluted and amitriptyline shifted in front of nortriptylene. For identification, the UV spectra were used and the different peak heights. At 6% formic acid, it became obvious that protriptylene and trimiprae will coelute. In a further step, the method was transferred to a column with smaller id and lower flow rates. Typically, MS analysis is done with 2.1-mm id columns and flow rates of about. ml/. 1 % phosphate buffer % NH 4 2% phosphate buffer 8% NH 4 4% phosphate buffer 6% NH 4 1. Protriptylene 2. Trimiprae 3. Nortriptylene 4. Imiprae. Amitriptylene 6% phosphate buffer 4% NH 4 8% phosphate buffer 2% NH 4 % phosphate buffer % NH 4 1 2 3 4 2 4 6 8 12 14 Figure 2. Separation of antidepressants using ammonium acetate as MS compatible modifier. 1+2 4 8 3 % phosphate buffer % FA 2% phosphate buffer 8% FA 1. Protriptylene 2. Trimiprae 3. Nortriptylene 4. Imiprae. Amitriptylene 6 4% phosphate buffer 6% FA 4 1 6% phosphate buffer 4% FA 2 3 4 8% phosphate buffer 2% FA % phosphate buffer % FA 4 6 8 12 Figure 3. Separation of antidepressants using formic acid (FA) as MS compatible modifiers. 6

The MS method based on formic acid was transferred to a 129 Infinity Binary LC/MS system, (Figure 4). A ZORBAX RRHT Eclipse Plus C18, 2.1 mm, 1.8 µm column was used. The flow was reduced to.4 ml/, the column temperature was raised to C and the injection volume was reduced to. µl. The developed MS method with formic acid provided complete elution of peaks within utes with clear identification. 12 8 6 4 8 6 4 2 2 1 8 6 4 2 TIC 1 2 3 4 Imiprae 1 2 3 4 Trimiprae 1 2 3 4 Amitriptylene 1 2 3 4 Protriptylene Nortriptylene 1 2 3 4 Figure 4. Analys is of tricyclic antidepressants after transfer to the Agilent 129 Infinity Binary LC/MS system using extracted ion chromatograms. Conclusion The transfer of a non-ms compatible method to a method which is applicable to a LC/MS system can be done on an Agilent 129 Infinity Quaternary LC System using a dedicated workflow. The modifier, which is not compatible with MS, is stepwise replaced by a modifier which is usable on a MS. Peak tracking was done using peak height and UV spectra. The stepwise change to the different modifier facilitated the tracking of peaks. At the end, a method was created which was compatible with MS and the elution series was known and could be compared to the primary LC chromatogram. 7

www.agilent.com/chem/129 This information is subject to change without notice. Agilent Technologies, Inc., 13 Published in the USA, June 1, 13 991-243EN